Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMSB15B antisense RNA 1 (TMSB15B-AS1) is a long noncoding antisense RNA (asRNA) gene annotated in the human genome. It is transcribed from the region opposite to the protein-coding gene TMSB15B, which codes for Thymosin Beta 15B, an actin-binding protein involved in cell migration and cytoskeletal dynamics. As a noncoding antisense transcript, TMSB15B-AS1 may modulate the expression of the TMSB15B gene or influence chromatin state locally, although its specific biological roles and functions are not well characterized in current literature. The general class of antisense RNAs is implicated in gene regulation via base pairing with sense mRNA, affecting RNA stability, transcription, or translation, and may function in cis or trans depending on context, but no disease association or pharmacological targeting for this specific antisense RNA is established.
No drugs targeting this molecule have characterized mechanisms of action.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TMSB15B antisense RNA 1 (TMSB15B-AS1).